RNF166 Activators
RNF166 Activators encompass a diverse range of chemical compounds that indirectly enhance the ubiquitin ligase activity of RNF166 through various cellular pathways. Forskolin, by increasing intracellular cAMP, indirectly boosts the ubiquitination capacity of RNF166 through the activation of PKA, which phosphorylates potential substrates for RNF166. Similarly, Ionomycin, through its calcium ionophore activity, raises intracellular calcium levels that might promote calcium-dependent ubiquitination processes where RNF166 could be more active. Phorbol 12-myristate 13-acetate (PMA) functions as a PKC activator, and the subsequent signal transduction modifications could result in PKC-phosphorylated substrates that are preferentially targeted by RNF166.
The activity of RNF166 is also potentially augmented by compounds that affect protein phosphorylation and stability. Calyculin A and Okadaic acid, both inhibitors of protein phosphatases PP1 and PP2A, might increase the pool of phosphorylated proteins, which are recognized and ubiquitinated by RNF166. Inhibition of GSK-3 by Lithium chloride and SB216763 is likely to lead to the accumulation of GSK-3 substrates, enhancing the variety of substrates available for RNF166-mediated ubiquitination. Lastly, PYR-41 inhibits the ubiquitin-activating enzyme E1, potentially leading to an increased pool of free ubiquitin which RNF166 can utilize to tag substrates for degradation, thereby indirectly enhancing its functional activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly raises cAMP levels, which can lead to the activation of PKA. PKA phosphorylates various substrates including those that may be ubiquitinated by RNF166, thus enhancing RNF166's E3 ligase activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, elevating intracellular calcium concentration and potentially stimulating calcium-dependent ubiquitination processes where RNF166 could be more active. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that modulates signal transduction pathways; activated PKC could phosphorylate substrates that are better recognized by RNF166, increasing its ubiquitination activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
As an inhibitor of protein phosphatases PP1 and PP2A, Calyculin A may increase phosphorylation levels of proteins, which could be recognized by RNF166, thus enhancing its E3 ubiquitin ligase activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is also a potent inhibitor of PP1 and PP2A, potentially leading to an increased pool of phosphorylated substrates for RNF166-mediated ubiquitination. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, which may lead to the stabilization and accumulation of proteins that are potential substrates for RNF166, enhancing its activity. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763 is a GSK-3 inhibitor that, similar to lithium chloride, may lead to an increase in potential substrates for RNF166, thereby potentially enhancing its ubiquitin ligase function. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
PYR-41 is a ubiquitin-activating enzyme E1 inhibitor, leading to reduced ubiquitin conjugation and potentially increasing the available pool of free ubiquitin for RNF166-mediated ligase activity. | ||||||